From 1979 to 1989 the p53 protein was alternatively referred to as a fetal antigen expressed in the teratocarcinoma stem cells, a tumor antigen that induced antibodies in animals and humans with tumors, an oncogene whose mutant forms could transform cells, and, finally, a tumor suppressor gene that prevented cancers. The gene discussed is TP53; the disease is teratocarcinoma.